Compare GSK plc (GSK) vs PAGSEG Inc (PAGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs PAGSEG Inc — how do they compare? GSK plc trades at $46.5 (market cap $91.88B), while PAGSEG Inc trades at $11.16 (market cap $2.94B). The key difference: GSK plc is far larger — about 31.3× PAGSEG Inc's market cap, and PAGSEG Inc pays the higher dividend (10.49%). Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and PAGSEG Inc for 26 Days on average.
| GSK | PAGS | |
|---|---|---|
Market Cap | $91.88B | $2.94B |
Volume | 7,730,529 | 4,242,708 |
Sector | Health | Industrials |
52-Week High | $61.18 | $12.00 |
52-Week Low | $43.24 | $8.44 |
Typical Hold Time | 93 Days | 26 Days |
Enterprise Value | $111.88B | $11.02B |
Dividend Yield | 3.9% | 10.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $46.54, down 1.02% with bearish technical signals but strong fundamentals including 29.73% ROE and consistent earnings beats. The company maintains robust profitability with 72.73% gross margins and is actively expanding its oncology pipeline through strategic partnerships. Recent developments include a $750M cancer therapy acquisition and advancing mRNA vaccine candidates.
GSK presents a mixed outlook with strong operational performance offset by technical weakness. Investment appeal lies in valuation multiples below industry averages and pipeline expansion, though risks include HIV patent expirations and manufacturing restructuring. Analyst consensus leans cautious with 55% hold ratings amid near-term headwinds.
PagSeguro Digital (PAGS) trades at $10.68, up 1.62% with strong bullish technical signals from moving averages. The stock shows attractive valuation metrics with P/E of 7.1 and P/S of 0.74, while maintaining solid profitability with 10.45% net margin and 14.54% ROE. Recent Q2 2026 earnings beat expectations at $0.41 per share, and the company announced a $0.28 dividend for H2-2026, supporting investor returns.
PAGS presents value opportunity with discounted valuation and dividend yield, though faces execution risks amid Brazilian macroeconomic challenges. Analyst consensus remains strongly bullish with 62.5% buy ratings and $10.70 price target, but investors should monitor credit portfolio performance and interest rate sensitivity in current high-rate environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About PAGSEG Inc
PagSeguro Digital Ltd. is a leading provider of financial technology solutions in Brazil, primarily focused on e-commerce, face-to-face transactions, and financial services. The company's main offerings include PagBank, a digital banking platform, and PagSeguro, a suite of payment processing solutions that includes point-of-sale devices and online payment gateways. PAGS targets micro-merchants, small and medium-sized enterprises (SMEs), and consumers, aiming to democratize access to financial services in the country.
Read more on PAGS →
